Bahrain Pharmaceuticals and Healthcare Report Q4 2009

Executive Summary .5
SWOT Analysis6
Bahrain Pharmaceuticals And Healthcare Industry SWOT . 6
Bahrain Political SWOT .. 7
Bahrain Economic SWOT. 8
Bahrain Business Environment SWOT 8
Pharmaceutical Business Environment Ratings 9
Table: Middle East And Africa Pharmaceutical Business Environment Ratings for Q409 9
Limits of Potential Returns .. 9
Risks to Realisation of Returns 10
Bahrain – Market Summary..12
Regulatory Regime.13
Recent Regulatory Developments .. 13
GCC Healthcare Collaboration.. 14
Intellectual Property Developments.. 16
Pricing and Reimbursement Regime. 16
Regional Price Harmonisation 17
Free Trade Agreement with the US 18
Other Free Trade Agreements . 19
Industry Developments21
Epidemiology 21
Table: Leading Causes Of Death In Bahrain, 2002 .. 23
HIV/AIDS 23
Healthcare Sector .. 23
Primary, Secondary and Tertiary Healthcare.. 24
Health Insurance 25
Table: National Health Insurance Scheme Breakdown 26
Strategic Healthcare Goals 27
Healthcare Sector Investment .. 30
Features Of Dilmunia Health Island. 31
Pharmaceutical Sector. 31
Pharmaceutical Retail . 32
Research and Development 32
International Collaboration.. 33
Medical Devices.. 34
Industry Forecast Scenario 36
Overall Market Forecast. 36
Table: Bahrain - Drug Expenditure Indicators, Historical Data and Forecasts.. 37
Key Growth Factors – Industry 38
Table: Bahrain - Health Expenditure Indicators, Historical Data and Forecasts .. 39
Key Growth Factors – Macroeconomic .. 40
Table: Bahrain – Economic Activity, 2006-2013 42
Prescription Market Forecast .. 43
Table: Bahrain – Prescription Market Indicators, Historical Data and Forecasts (US$mn unless otherwise indicated) 44
Patented Market Forecast.. 45
Table: Bahrain – Prescription Drug Market Indicators, Historical Data and Forecasts. 45
Generics Drug Market Forecast . 46
Table: Bahrain – Generics Drug Market Indicators, Historical Data and Forecasts 47
OTC Market Forecast.. 48
Table: Bahrain - OTC Market Indicators, Historical Data and Forecasts (US$mn unless otherwise stated) 49
Pharmaceutical Trade Forecast . 50
Table: Bahrain – Pharmaceutical Trade Balance Indicators, Historical Data and Forecasts (US$mn) . 51
Medical Devices.. 52
Table: Bahrain – Medical Device Market Indicators, Historical Data and Forecasts.. 52
Other Healthcare Data Forecasts.. 53
Table: Bahrain – Other Health Indicators, Historical Data and Forecasts, 2003-2013.. 54
Key Risks to BMI’s Forecast Scenario. 55
Competitive Landscape..56
Company Monitor57
Multinational Companies.. 57
Novartis .. 57
Johnson & Johnson (J&J) . 59
Merck & Co .. 61
Pfizer 62
GlaxoSmithKline. 63
GlaxoSmithKline. 64
Indigenous Companies 65
Bahrain Industrial Pharmaceutical Co (Bidapharm) 65
Al-Jishi Corporation. 66
Behzad Medical Establishment 67
Yousuf Mahmood Husain Company.. 68
Country Snapshot: Bahrain Demographic Data ..69
Section 1: Population 69
Table: Demographic Indicators, 2005-2030. 69
Table: Rural/Urban Breakdown, 2005-2030 70
Section 2: Education and Healthcare .. 70
Table: Education 70
Table: Vital Statistics, 2005-2030.. 70
Section 3: Labour Market and Spending Power . 71
Table: Employment Indicators. 71
Table: Consumer Expenditure, 1999-2004 (US$) .. 71
Table: Average Annual Wages. 71
BMI Methodology 72
How We Generate Our Pharmaceutical Industry Forecasts 72
Pharmaceutical Business Environment Ratings Methodology 73
Ratings Overview 73
Table: Pharmaceutical Business Environment Indicators . 74
Weighting 75
Table: Weighting Of Components.. 75
Sources .. 75